Navigation Links
Royalty Pharma Announces Proposal To Acquire Elan

y one of them;"Elan Stock"

Elan Shares and/or Elan ADS;"Irish Takeover Rules"

the Irish Takeover Panel Act 1997, Takeover Rules 2007 (as amended);"J.P. Morgan"

J.P. Morgan Securities LLC;"Large Cap Biotech Companies"

Amgen Inc., Biogen, Celgene Corporation and Gilead Sciences, Inc.;"Offer Period"

the period commencing on the date of this announcement and ending on such date as the Irish Takeover Panel may decide or the Irish Takeover Rules dictate;"Proposal Enterprise Value"

the enterprise value of Elan implied by the Proposal, calculated by Royalty Pharma in accordance with Appendix II;"Prothena"

Prothena Corporation plc;"SEC"

Securities and Exchange Commission;"Specialty Pharma Companies"

Alkermes plc, Allergan, Inc., Cubist Pharmaceuticals, Inc., Endo Health Solutions Inc., Forest Laboratories, Inc., Jazz Pharmaceuticals plc, The Medicines Company, Salix Pharmaceuticals, Ltd., Shire plc, Valeant Pharmaceuticals International, Inc and Warner Chilcott Plc;"Tysabri Royalty"

the royalty on Tysabri payable by Biogen to Elan Group following the completion of the Tysabri Transaction; and"Tysabri Transaction"

the transaction between Elan and Biogen in relation to the restructuring of Elan's Tysabri collaboration with Biogen which was announced by Elan on February 6, 2013.  APPENDIX II: Calculation of Current Enterprise Value and Proposal Enterprise ValueTable 1 - Enterprise Value (US$m unless stated)Current
ValuePrice of Elan Stock

US$10.35[11]US$11.00Fully diluted number of Elan Stock outstanding (m) – Table 2


602.0Market capitalization


6,622.4Elan net cash – Table 3


3,091.4Enterprise value3,135.53,531.0 Table 2 – Fully diluted shares (m unless stated)

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
3. Health Outcomes Liaisons (HOLs) Serve as Key Bridge between Pharmaceutical Sector and Managed Care Groups
4. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
5. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
7. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
8. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
9. Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
10. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Post Your Comments:
(Date:10/8/2015)... 08 2015 ... "Global API Market Outlook 2020" report to ... announced the addition of the "Global API ... --> Research and Markets ( ... "Global API Market Outlook 2020" report to ...
(Date:10/8/2015)... Oct. 8, 2015  CareDx, Inc. (NASDAQ: CDNA ), ... a recent proposal by the Centers for Medicare & Medicaid ... test AlloMap, which measures gene expression levels to help clinicians ... See latest coverage of this story on CNBC ... coverage of this story on CNBC . [ ...
(Date:10/8/2015)... 2015 Hill-Rom Holdings, Inc., (NYSE: HRC ... conference call and webcast from 8:00 a.m. – 9:00 ... 2015. . --> ... will be issued that morning prior to the call ... . .  The webcast slide ...
Breaking Medicine Technology:
... (Nasdaq: QCOR ) today announced that it will ... ended December 31, 2010 on Wednesday, February 23, 2011 after ... host a conference call and webcast on Wednesday, February 23, ... discuss results and highlights of the fourth quarter and full ...
... Ala., Feb. 5, 2011 Qualitest Pharmaceuticals today ... and Acetaminophen Tablets, USP 10mg / 500mg, NDC ... T023M10A, and Phenobarbital Tablets, USP 32.4 mg, NDC ... T023M10A. An individual bottle of Hydrocodone Bitartrate and ...
Cached Medicine Technology:
(Date:10/9/2015)... , ... October 09, 2015 , ... ... their “Agents of Change” program, a community improvement initiative that involves working with ... to benefit from the assistance of Confidence Plus Insurance is the Gleason Park ...
(Date:10/9/2015)... ... October 09, 2015 , ... "As a nurse, I care ... Philadelphia, Pa. "They have to wear large diapers or pads. We came up with ... the TROUSAFE to absorb urine leaking from the tip of the penis. This prevents ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... of Innovations with Ed Begley Jr., airing 1st QT 2016 via the Discovery ... audiences on MMJ Phytotech Limited (MMJ) – a global leader in the field ...
(Date:10/9/2015)... ... 2015 , ... Santa Rosa Consulting and The University of Texas MD Anderson ... on the Epic platform in March of 2016. Both entities have already begun preparation ... contract by supporting Scheduling Appointment Conversion and the Go-Live. , “We are honored ...
(Date:10/9/2015)... ... 09, 2015 , ... Deadly, record-smashing rainfall has caused massive ... in Columbia, South Carolina. In response, the Foundation has established a national S.C. ... short and long term. 100% of monies donated will go directly to local ...
Breaking Medicine News(10 mins):
... LAS VEGAS, Nov. 20 /Xinhua-PRNewswire-FirstCall/ -- China ... and its subsidiaries,engage in multiple China-focused business ... real estate, and,pharmaceuticals, announced today the Company ... and construct its 3rd Biomass Energy Power,Generation ...
... suggests worsening coronary artery disease, study finds , TUESDAY, ... of a protein called albumin in the urine of ... of cardiovascular death, say U.S. researchers. , The findings ... and older, with stable coronary artery disease (CAD) have ...
... Cellmark Inc.,(Nasdaq: ORCH ), a leading worldwide ... appointment of William J. Thomas, Esq. as,Vice President ... Senior Vice President and General Counsel for,Cytogen Corporation ... outside general and intellectual property counsel. Prior to,joining ...
... Nov. 20 ATS Medical, Inc.,(Nasdaq: ATSI ), ... today announced that it will present at the,19th Annual ... in New,York City on Wednesday, November 28, 2007, at ... ATS Medical, will present a review of,the Company,s historical ...
... Nov. 20 Many Americans,anticipate that the holiday season ... however, according to a recent survey conducted by Ipsos ... can take its,toll. In fact, 61 percent of respondents ... percent said they would like more alone time with,their ...
... Nov. 20 The Oral Cancer,Foundation announced today that ... would be the foundation,s first grant recipients. The ... each,researcher, were awarded to Dr. Maura Gillison of Johns ... of California at Los Angeles,and Dr. Ann Gillenwater of ...
Cached Medicine News:
... silicone tip cannula allows atraumatic ... hole for aspiration of subretinal ... 6mm beyond end of cannula. ... easy, secure connection to a ...
PLX30s, 30 Watt Sealed CO2 Laser System....
... CO2 laser is ideal for small clinics ... delivery system, it combines the advantages of ... scalpel-like feel. The Novapulse system delivers short-duration, ... during which tissue is allowed to cool ...
The compact size and portability of the Epic system makes it a cost-effective solution for single or multi-office use....
Medicine Products: